Baxter To Exit Drug Price Inflation MDL For $30M

By Roxanne Palmer · October 7, 2011, 4:49 PM EDT

Baxter Healthcare Corp. on Friday reached a $29.8 million settlement in Massachusetts with the relator in multidistrict litigation accusing pharmaceutical companies of reporting inflated average wholesale prices of drugs to Medicaid...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Citizens for Consume, et al v. Abbott Laboratories,, et al

Case Number

Court

Massachusetts

Nature of Suit

Anti-Trust

Date Filed

December 19, 2001

Recent Articles By Roxanne

March 13, 2012
Pfizer Won't Get To Trim BYU's Bextra-Celebrex Suit
February 29, 2012
3rd Circ. Says AIG Unit Doesn't Owe Hospital Group Coverage
February 22, 2012
Wash.'s Contraceptive Sales Rules Unconstitutional: Judge
February 15, 2012
Calif. High Court Takes Up Cipro Pay-For-Delay Suit
February 07, 2012
Illumina Board Urges Investors To Reject $6B Roche Bid
February 03, 2012
FTC Won't Get Monitor For ProMedica Hospital Operations
January 25, 2012
Takeda Hid Gout, GERD Drug Interactions: Whistleblower
December 21, 2011
NY Court Sets Test For Summary Judgment In Bias Cases
December 16, 2011
HHS To Let States Set Benefit Benchmarks For Health Plans
December 06, 2011
Pfizer Hit With $73M Verdict In Menopause Drug Suit